Elsevier vs MarketsandMarkets

Updated generative AI policies for journals: supporting responsible use while protecting trust

Elsevier updates generative AI policies for journals to support responsible use while protecting trust.

How NHS 24 and Elsevier are turning uncertainty into confident, clinically safe decisions

The featured story on the Elsevier About page has been updated from 'The future we build could depend on research we don’t read' to a new case study about NHS 24, highlighting a partnership to improve clinical decision-making.

XDR Market to Reach $38.09 Billion by 2031

A new report from MarketsandMarkets projects the Extended Detection and Response (XDR) market to grow from USD 10.98 billion in 2026 to USD 38.09 billion by 2031, at a CAGR of 28.2%. The growth is driven by increasing complexity of hybrid and multi-vendor IT environments, which require integrated visibility across endpoints, network, cloud, email, and identity. The report highlights that the services segment will grow at a CAGR of 29.5%, while open/multivendor XDR is expected to grow fastest among platform types at 30.3%. North America is expected to account for the largest market share in 2026. Key vendors mentioned include CrowdStrike, Palo Alto Networks, Microsoft, Cisco, and SentinelOne. The report also notes recent M&A activity, such as Palo Alto Networks' acquisitions of Console and Koi, and SentinelOne's acquisition of Observo AI.

• XDR market projected to grow from USD 10.98 billion in 2026 to USD 38.09 billion by 2031 at a CAGR of 28.2%.
• Services segment expected to grow at a CAGR of 29.5% during the forecast period.
• Open/multivendor XDR segment projected to grow fastest at a CAGR of 30.3%.

Clinical Trial Supplies Market to Reach $8.95B by 2031

MarketsandMarkets forecasts the clinical trial supplies market to grow from USD 5.60 billion in 2026 to USD 8.95 billion by 2031, at a CAGR of 8.9%. The report highlights logistics and distribution as the largest service segment, small molecules as the dominant molecule type, and oncology as the leading therapeutic area. North America accounts for over 41.4% of global revenue. Key drivers include rising clinical trial numbers, increased R&D spending, and decentralized trial adoption. The report also details major M&A activity, including DHL's acquisition of CRYOPDP and UPS's acquisition of Andlauer Healthcare Group, reflecting consolidation in cold-chain logistics.

• Market projected to grow from USD 5.60 billion in 2026 to USD 8.95 billion by 2031 at a CAGR of 8.9%.
• Logistics and distribution held the largest service segment share of 27.2% in 2025.
• North America accounted for over 41.4% of global revenue in 2025.

What Are Customer Journey Management Platforms?

Customer journey management platforms connect cross-channel customer data with analytics and action, helping teams identify pain points and improve experiences. Unlike static journey maps, these platforms use live data to show what customers actually do. They integrate with CRM, CDP, and marketing automation systems. The customer experience management market is projected to grow from $15.78 billion in 2026 to $34.02 billion by 2032, with journey management as the largest segment. Adobe's 2026 survey found only 39% of organizations have a data foundation ready for agentic AI. Forrester's Q4 2025 Wave evaluated vendors including JourneyTrack, TheyDo, and Cemantica.

• MarketsandMarkets projects the customer experience management market will grow from $15.78 billion in 2026 to $34.02 billion by 2032.
• Adobe's 2026 survey of 3,000 executives found only 39% had a shared CDP capable of supporting widespread agentic AI adoption.
• Qualtrics' 2026 research found only three in 10 customers provide direct feedback.